Baylor | GenomeWeb

Baylor

The two new single-cell RNA-sequencing methods aim to overcome some of the limitations of single-cell transcriptomics.

Multiple molecular disease diagnoses were made in nearly 5 percent of individuals where exome sequencing was informative.

This Week in PLOS

In PLOS this week: chromosomal insertion mechanisms, phylogeographic analysis of the Crimean Congo hemorrhagic fever virus, and more.

Asian long-horned beetle

With a newly sequenced Asian long-horned beetle genome and comparative genomics, researchers identified genes involved in the insect's damaging lifestyle.

Several academic and commercial groups are developing clinical cell-based noninvasive prenatal tests, which could eventually compete with current cell-free NIPTs.

A genomic look at estrogen receptor-positive tumors before and after neoadjuvant aromatase inhibitor therapy suggests ongoing molecular monitoring may be needed.

Molecular Autopsy Consortium of Houston members outlined their recommendations for using molecular autopsy to investigate unexplained deaths in young people. 

The joint center will, among other things, design, establish, and conduct training in clinical genetics and genetic counseling tailored to key Asian regions.

Magdalena Walkiewicz from Baylor College of Medicine and Carin Yates from GeneDx presented their labs' initial findings from exome sequencing of fetal DNA samples.

Tampa Convention Center, site of the 2016 ACMG Meeting

At the ACMG annual meeting, researchers from Baylor and Johns Hopkins reported on strategies for improving the diagnostic rate of exome sequencing.

Pages

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.